Author

O. Ogunwobi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

C. U. Awah· 2 shared J. Winter· 2 shared C. M. Mazdoom· 1 shared C. Santamaria· 1 shared J. Huaman· 1 shared K. Huang· 1 shared M. Holford· 1 shared M. Hossain· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. U. Awah

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Intracellular interaction of FNDC1/FN1/AR/cMYC in prostate cancer cells

P. Ghosh, O. Ogunwobi

The paper investigates the interaction of FNDC1/FN1/AR/cMYC in prostate cancer cells and finds they physically interact, with FN1/AR/cMYC also interacting in normal cells.

bioRxiv · Feb 23, 2023 · PreprintCancer Biology

Genome scale CRISPR Cas9a knockout screen reveals genes that controls glioblastoma susceptibility to the alkylating agent temozolomide

C. U. Awah, J. Winter, O. Ogunwobi

This study uses a genome-wide CRISPR-Cas9a knockout screen to identify genes influencing glioblastoma resistance to temozolomide.

bioRxiv · Aug 11, 2021Cancer Biology

NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to Temozolomide (TMZ) via NELFB and RPS6KB2 interaction.

C. U. Awah, J. Winter, C. M. Mazdoom, O. Ogunwobi

This study identifies NSUN6 as an RNA methyltransferase that regulates glioblastoma response to temozolomide through 5mC-mediated control of NELFB and RPS6KB2.

bioRxiv · Aug 11, 2021Cancer Biology

Antitumor effects of Tv1 venom peptide in liver cancer

P. Anand, P. Filipenko, J. Huaman, M. Lyudmer, M. Hossain, C. Santamaria, K. Huang, O. Ogunwobi, M. Holford

This study shows that Tv1, a venom peptide from Terebra variegata, inhibits liver cancer cell proliferation and reduces tumor size in mice by targeting TRP channels and downregulating COX-2.

bioRxiv · Jan 26, 2019 · PreprintCancer Biology